The Compound Investor
  • Stocks
  • ETFs
  • Portfolio
  • Dividend Millionaires
  • Archive
  • Contact
Daily Archives

March 30, 2021

  • StocksHealthcare

    Johnson & Johnson: Dividend Aristocrat At A Fair Price For Long-Term Investors

    by The Compound Investor March 30, 2021
    March 30, 2021

    Although it comes under a single ticker, Johnson & Johnson (JNJ) is more akin to a giant one-stop healthcare shop. Folks likely know the consumer division thanks to brands like Listerine, Neutrogena and Tylenol. Its pharmaceutical segment sells patented drugs across a range of areas – oncology, immunology, neurology, infectious…

Load More Posts

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Article Calendar

March 2021
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
« Feb   Apr »

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Post Calendar

March 2021
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
« Feb   Apr »

Recent Articles

  • VYMI: International Blue Chip Dividend ETF; Still Reasonable Long-Term Value April 21, 2021
  • Molson Coors: Looking To Turn The Corner With Dividends Resuming In 2021 April 16, 2021
  • Toronto Dominion: Set For A Good 2021, But A Return To Pre-COVID Performance Now Reflected In The Share Price April 8, 2021
  • Privacy Policy
  • Contact
  • About

©2021 thecompoundinvestor.com - All Right Reserved.


Back To Top
  • Stocks
  • ETFs
  • Portfolio
  • Dividend Millionaires
  • Archive
  • Contact